期刊文献+

雷公藤内酯与辅酶Q_10联合干预MPP^+帕金森模型大鼠的作用及其机制 被引量:3

下载PDF
导出
摘要 目的:探讨雷公藤内酯与辅酶Q10(Co Q10)联合干预1-甲基-4-苯基-吡啶(MPP+)帕金森(PD)模型鼠的效果及其机制。方法:MPP+黑质内注射建立PD大鼠模型。将制作成功的模型大鼠随机分为假手术组、模型组、雷公藤内酯组、Co Q10组和联合给药组。对比各组行为学、TH、OX-42免疫荧光、Western blot结果、线粒体酶复合体I(Complex I)活性。结果:雷公藤内酯与Co Q10均可部分减轻MPP+诱导的PD模型鼠行为学缺陷,联合给药效果优于单一用药。TH阳性神经元数量联合给药组比雷公藤内酯组(P<0.01)及Co Q10组(P<0.01)显著增多。雷公藤内酯组及联合给药组CX3CR1蛋白表达量均较模型组低(P<0.01)。Co Q10组及联合给药组可使Complex I的活性增高(P<0.01)。结论:CX3CR1抑制剂与线粒体Complex I增强剂联合给药较单一给药对MPP+PD大鼠模型具有更好的神经保护作用。
出处 《实用医学杂志》 CAS 北大核心 2015年第1期31-34,共4页 The Journal of Practical Medicine
基金 国家自然科学基金项目(编号:81373712)
  • 相关文献

参考文献11

  • 1Faust-Socher A, Kenett YN, Cohen OS, et al. Enhanced creative thinking under dopaminergic therapy in Parkinson disease [J]. Ann Neurol, 2014, 75(6):935-942.
  • 2Beal MF, Oakes D, Shoulson I, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit [J]. JAMA Neurol, 2014, 71 (5) : 543- 552.
  • 3Gao JP, Sun S, Li WW, et al. Tnptolide protects against 1- methyl-4-phenyl pyrldinium-indueed dopaminergic neurotoxieity in rats : implication for immunosuppressive therapy in Parkinson's disease [J]. Neurosci Bull, 2008, 24(3):133-142.
  • 4Shan S, Hong-Min T, Yi F, et al. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral ehanges in a rat model of Parkinson's disease [J]. Neurobiol Aging, 2011, 32 (3): 443-458.
  • 5Tfistao FS, Amar M, Latrous I, et al. Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyr- idine (MPTP) administration in mice, an experimental model of Parkinson's disease [J]. Neurotox Res, 2014, 25 (1) :24- 32.
  • 6Emmrich JV, Hornik TC, Neher JJ. Rotenone induces neuronal death by microglial phagocytosis of neurons [J]. FEBS J, 2013, 280(20) :5030-5038.
  • 7Chinta SJ, Ganesan A, Reis-Rodrigues P, et al. Anti- inflammatory role of the isoflavone diadzein in lipopolysaccharide- stimulated microglia: implications for Parkinson's disease [J]. Neurotox Res, 2013, 23(2): 145-153.
  • 8Garcia JA, Cardona SM, Cardona AE. Analyses of microglia effector function using CX3CR1-GFP knock-in mice [J]. Methods Mol Biol, 2013, 1041:307-317.
  • 9Lee S, Varvel NH, Konerth ME, et al. CX3CRI deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models [J]. Am J Pathol, 2010, 177 (5) : 2549-2562.
  • 10华海应,高华强,孙爱宁,朱文艳,姜东林,岑建农,吴丽丽.雷公藤内酯醇诱导SKM-1细胞凋亡机制研究[J].实用医学杂志,2013,29(22):3630-3632. 被引量:4

二级参考文献10

共引文献3

同被引文献38

  • 1Sirtori CR. The pharmacology of statins [J]. Pharmacol Res, 2014,88: 3-11.
  • 2Li Q, Zhuang QK, Yang JN, et al. Statins excert neuroprotection on cerebral ischemia independent of their lipid- lowering action: the potential molecular mechanisms [J]. Eur Rev Med Pharmacol Sci, 2014,18 ( 8 ) : 1113-1126.
  • 3Vollmer T, Key L, Durkalski V, et al. Oral simvastatin treatment in relapsing-remitting multiple sclerosis [J ]. Lancet, 2004,363 ( 9421 ) : 1607 - 1608.
  • 4Chataway J, Schuerer N, Alsanousi A, et al. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT) : a randomised, placebo-controlled, phase 2 trial [J]. Lancet, 2014,383 (9936) :2213-2221.
  • 5Nath N, Giri S, Prasad R, et al. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy [J]. J Immunol, 2004,172(2) : 1273-1286.
  • 6Roy K, Ghosh M, Pal TK, et al. Cholesterol lowering drug may influence cellular immune response by altering MHC lI function ~JJ. J Lipid Res, 2013,54(11) :3106-3115.
  • 7Ulivieri C, Baldari CT. Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Thl7-mediated autoimmune diseases [ J ]. Pharmacol Res, 2014,88 : 41-52.
  • 8McFarland AJ, Anoopkurnar-Dukie S, Arora DS, et al. Molecular mechanisms underlying the effects of statins in the central nervous system [ J ]. Int J Mol Sei, 2014,15 ( 11 ) : 20607- 20637.
  • 9Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia [J]. Lancet, 2000,356(9242) : 1627-1631.
  • 10Lee H J, Korshavn KJ, Kochi A, et al. Cholesterol and metal ions in Alzheimer' s disease [ J ]. Chem Sac Rev, 2014,43 (19) : 6672-6682.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部